Susquehanna International Group, LLP Jounce Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	BUY	$0.9 - $1.85 $71,104 - $146,159	79,005 Added 269.72%	108,297 $200,000
Q4 2022 Feb 14, 2023	BUY	$0.64 - $1.99 $4,496 - $13,979	7,025 Added 31.55%	29,292 $32,000
Q3 2022 Nov 14, 2022	SELL	$2.73 - $4.92 $51,837 - $93,420	-18,988 Reduced 46.03%	22,267 $52,000
Q2 2022 Aug 15, 2022	BUY	$2.8 - $7.67 $81,611 - $223,557	29,147 Added 240.73%	41,255 $125,000
Q2 2021 Aug 11, 2021	SELL	$6.58 - $10.66 $65,892 - $106,749	-10,014 Reduced 45.27%	12,108 $82,000
Q1 2021 May 17, 2021	SELL	$6.73 - $13.87 $25,614 - $52,789	-3,806 Reduced 14.68%	22,122 $227,000
Q4 2020 Feb 16, 2021	BUY	$6.37 - $10.33 $76,510 - $124,073	12,011 Added 86.3%	25,928 $181,000
Q3 2020 Nov 16, 2020	SELL	$4.58 - $10.95 $157,588 - $376,767	-34,408 Reduced 71.2%	13,917 $114,000
Q4 2019 Feb 14, 2020	BUY	$2.81 - $9.21 $78,916 - $258,653	28,084 Added 138.75%	48,325 $422,000
Q3 2019 Nov 14, 2019	BUY	$3.33 - $4.93 $13,043 - $19,310	3,917 Added 24.0%	20,241 $67,000
Q2 2019 Aug 16, 2019	BUY	$4.3 - $6.73 $10,380 - $16,246	2,414 Added 17.35%	16,324 $81,000
Q2 2019 Aug 14, 2019	SELL	$4.3 - $6.73 $132,065 - $206,698	-30,713 Reduced 68.83%	13,910 $69,000
Q1 2019 May 15, 2019	BUY	$3.43 - $6.87 $64,878 - $129,946	18,915 Added 73.58%	44,623 $277,000
Q4 2018 Feb 14, 2019	SELL	$2.69 - $6.71 $408,003 - $1.02 Million	-151,674 Reduced 85.51%	25,708 $87,000
Q3 2018 Nov 14, 2018	BUY	$6.5 - $8.37 $822,705 - $1.06 Million	126,570 Added 249.09%	177,382 $1.15 Million
Q2 2018 Aug 14, 2018	SELL	$7.27 - $21.88 $338,331 - $1.02 Million	-46,538 Reduced 47.8%	50,812 $389,000
Q1 2018 May 15, 2018	BUY	$13.4 - $28.4 $1.13 Million - $2.4 Million	84,531 Added 659.42%	97,350 $2.18 Million
Q4 2017 Feb 14, 2018	BUY	$12.52 - $17.82 $160,493 - $228,434	12,819	12,819 $163,000

Others Institutions Holding JNCE

# of Institutions

Shares Held

720K

Call Options Held

Put Options Held

View Full List

About Jounce Therapeutics, Inc.

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

More about JNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account